- About us
- A new Institute dedicated to combating Leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- Institute Governance
- Press Room
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Establishment of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Laureates of the first call for projects of the Leukemia Institute
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Anti-cancer Treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Department of clinical hematology
- Department of adult hematology
- Hematology Transplant Unit
- Department of Pharmacology and Clinical Investigations
- Department of clinical hematology and cell therapy
- Adolescent and Young Adult Unit
- Outpatient Hemato-oncogenetics Unit
- Department of senior hematology
- Department of pediatric hematology and immunology
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient Information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Anti-cancer Treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Molecular pathology
- Functional precision medicine for leukemia
- Normal and pathological hematopoiesis
- Niche, Cancer, and Radiation in Hematopoiesis
- Population Evolution and Interaction Particle Systems
- Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Identification and targeting of extrinsic regulators of myeloid malignancies
- Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Molecular Mechanisms of Acute Myeloid Leukemia Development
- Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Leukemia & Niche Dynamics
- Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Stem cell dysfunction and secondary AML
- Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
Accueil » Molecular Genetics Unit, Hélène CavéMolecular Genetics Unit, Hélène Cavé
...Hélène Cavé
Robert Debré Hospital
48 boulevard Sérurier
75019 Paris
Diseases
Childhood leukaemia: Acute lymphoblastic leukaemia
Juvenile myelomonocytic leukaemia
Genetic predisposition to malignant blood disorders
Rare genetic diseases, with a focus on neurodevelopment
Childhood leukaemia: Acute lymphoblastic leukaemia
Juvenile myelomonocytic leukaemia
Genetic predisposition to malignant blood disorders
Rare genetic diseases, with a focus on neurodevelopment
Department activities
The Molecular Genetics Unit at Robert Debré Hospital provides specialised hospital services in molecular biology. It is an accreditated facility for prenatal and postnatal diagnosis of genetic diseases, with a mission to develop the diagnosis and monitoring of rare constitutional and somatic diseases in children, in support of the Rare Disease Networks and Centres of Expertise (CRMR) and specialist departments within its hospital structure.
The UF organises and participates in national and international networks for diagnosis and translational research in the field of rare diseases and leukaemia in children.
The department includes medical staff , non-medical staff and clinical research staff :
- 9 hospital-based medical biologists or university hospital teaching staff in biochemistry – molecular biology at the Paris-Cité Faculty of Medicine
- 21 technicians
- 3 engineers
- 2 CRA
Our clinical research
To evaluate new prognostic factors in childhood ALL as part of large national or international studies, on behalf of the French Society for the Fight against Childhood Cancer and Leukaemia (SFCE).
To decipher RAS-related germline pathologies, such as Noonan syndrome and related RASopathies, and somatic pathologies, such as JMML, with a focus on age-related patterns and the specific involvement of alterations in the myelomonocytic lineage.
Team members
Cavé HélènePUPH, Head of DepartmentVial YoannMCU-PHCaye-Eude AuréliePHArfeuille ChloéPHHoutman ArnoEngineerFeatured research projects
Juvenile myelomonocytic leukaemia, a developmental disorder?
An emerging concept in paediatric oncology is that key processes in physiological ontogenesis are hijacked for tumour initiation and/or progression. Our project aims to better understand the link between childhood leukaemia (ALL, JMML) and foetal haematopoiesis.
Marion Strullu / Chloé Arfeuille
Circulating free DNA (cfDNA) and early clonal dynamics in leukaemia
Profiling and fragmentomics of cfDNA in children with ALL to assess tumour spatial heterogeneity and monitor early treatment phases.
Aurélie Caye / Arno Houtman
RASopathies and myelomonocytic lineage
Combining multiomic approaches and a dedicated European registry (RASORES) to evaluate the risk of leukaemia and study how SHP2-driven myelomonocytic lineage defects contribute to age-related diseases
H Cavé / A Bonnard
Job offers
Project Manager/Hospital Engineer
Project Manager/Hospital Engineer responsible for structuring the pathway of foetal and leukaemia human biological samples for scientific research purposes.
Download the PDFFollow our actions by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating Leukemia